{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:12:33Z","timestamp":1771823553327,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is an autoimmune disorder which often presents with neuropsychiatric symptoms. A large proportion of cases are associated with an identifiable tumor, most commonly ovarian teratoma. However, recent literature has also described an overlap of anti-NMDAR encephalitis and demyelinating syndromes. Cases have been reported of anti-NMDAR encephalitis in patients with ADEM, optic neuritis, myelitis and multiple sclerosis. This link is considered rare, however has important clinical implications as treatments and prognosis may differ.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 33-year-old female with a history of multiple sclerosis presented with new-onset neuropsychiatric symptoms. After substance-induced psychosis was ruled out, she was admitted to the medical ward for work up of psychosis secondary to multiple sclerosis. However, the consultation-liaison psychiatry service noted atypical symptoms which were concerning for autoimmune encephalitis. Admission to a psychiatric inpatient ward was deferred. Anti-NMDAR encephalitis was diagnosed with CSF analysis demonstrating lymphocytic pleocytosis and anti-NMDAR antibodies. In addition to first-line treatment of encephalitis with steroids, second-line immunotherapies were also implemented given the patient\u2019s underlining demyelinating syndrome. The patient\u2019s neurologic and psychiatric symptoms began to improve.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>There is literature to demonstrate a possible connection between anti-NMDAR encephalitis and demyelinating syndromes. As such, autoimmune encephalitis should be considered in patients with multiple sclerosis presenting with atypical symptoms. Determining the correct diagnosis is crucial to inform the appropriate treatment protocol, and to improve prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-021-03351-7","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T03:10:35Z","timestamp":1626059435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Anti-N-methyl-D-aspartate receptor encephalitis presenting as atypical psychosis in multiple sclerosis: a case report"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1084-6213","authenticated-orcid":false,"given":"Khushminder","family":"Chahal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Endeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Scapinello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Sapieha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,12]]},"reference":[{"issue":"1","key":"3351_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"J Dalmau","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10(1):63\u201374. https:\/\/doi.org\/10.1016\/S1474-4422(10)70253-2.","journal-title":"Lancet Neurol"},{"issue":"4","key":"3351_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391\u2013404. https:\/\/doi.org\/10.1016\/S1474-4422(15)00401-9.","journal-title":"Lancet Neurol"},{"issue":"2","key":"3351_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcomes in patients with anti-N-methyl-D-aspartate (NMDA) receptor encephalitis: a cohort study. Lancet Neurol. 2013;12(2):157\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(12)70310-1.","journal-title":"Lancet Neurol"},{"issue":"3","key":"3351_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ana.24117","volume":"75","author":"MJ Titulaer","year":"2014","unstructured":"Titulaer MJ, H\u00f6ftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, et al. Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis. Ann Neurol. 2014;75(3):411\u201328. https:\/\/doi.org\/10.1002\/ana.24117.","journal-title":"Ann Neurol"},{"issue":"1","key":"3351_CR5","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000002","volume":"1","author":"Y Hacohen","year":"2014","unstructured":"Hacohen Y, Absoud M, Hemingway C, Jacobson L, Lin JP, Pike M, et al. NMDA receptor antibodies associated with distinct white matter syndromes. Neurol Neuroinflammunol Neuroinflamm. 2014;1(1):e2. https:\/\/doi.org\/10.1212\/NXI.0000000000000002.","journal-title":"Neurol Neuroinflammunol Neuroinflamm"},{"issue":"18","key":"3351_CR6","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1212\/WNL.0b013e3181dc1a7f","volume":"74","author":"MC Kruer","year":"2010","unstructured":"Kruer MC, Koch TK, Bourdette DN, Chabas D, Waubant E, Mueller S, et al. NMDA receptor encephalitis mimicking seronegative neuromyelitis optica. Neurology. 2010;74(18):1473\u20135. https:\/\/doi.org\/10.1212\/WNL.0b013e3181dc1a7f.","journal-title":"Neurology."},{"issue":"13","key":"3351_CR7","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1007\/s00415-013-7182-x","volume":"260","author":"M Zoccarato","year":"2013","unstructured":"Zoccarato M, Saddi MV, Serra G, Pelizza MF, Rosellini I, Peddone L, et al. Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis. J Neurol. 2013;260(13):3185\u20137. https:\/\/doi.org\/10.1007\/s00415-013-7182-x.","journal-title":"J Neurol"},{"issue":"5","key":"3351_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1055\/s-2007-1004521","volume":"38","author":"N Ishikawa","year":"2007","unstructured":"Ishikawa N, Tajima G, Hyodo S, Takahashi Y, Kobayashi M. Detection of autoantibodies against NMDA-type glutamate receptor in a patient with recurrent optic neuritis and transient cerebral lesions. Neuropediatrics. 2007;38(5):257\u201360. https:\/\/doi.org\/10.1055\/s-2007-1004521.","journal-title":"Neuropediatrics."},{"issue":"1","key":"3351_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/1471-2377-13-211","volume":"13","author":"O Outteryck","year":"2013","unstructured":"Outteryck O, Baille G, Hodel J, Giroux M, Lacour A, Honnorat J, et al. Extensive myelitis associated with anti-NMDA receptor antibodies. BMC Neurol. 2013;13(1):211. https:\/\/doi.org\/10.1186\/1471-2377-13-211.","journal-title":"BMC Neurol"},{"key":"3351_CR10","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1186\/1756-0500-7-948","volume":"7","author":"A Waschbisch","year":"2015","unstructured":"Waschbisch A, et al. Demyelinating disease and anti-N-methyl-D-aspartate receptor immunoglobulin G antibodies: a case report. BMC Res Notes. 2015;7:948.","journal-title":"BMC Res Notes"},{"key":"3351_CR11","doi-asserted-by":"crossref","unstructured":"Suleman S, Javed Q. NMDAR (N-methyl-D-aspartate receptor) encephalitis in a patient with MS (multiple sclerosis): a rare and challenging case. BMJ Case Rep. 2018;2018:bcr-2017-222086.","DOI":"10.1136\/bcr-2017-222086"},{"issue":"4","key":"3351_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.clineuro.2011.10.047","volume":"114","author":"A Uzawa","year":"2012","unstructured":"Uzawa A, Mori M, Takahashi Y, Ogawa Y, Uchiyama T, Kuwabara S. Anti-N-methyl-D-aspartate-type glutamate receptor antibody-positive limbic encephalitis in a patient with multiple sclerosis. Clin Neurol Neurosurg. 2012;114(4):402\u20134. https:\/\/doi.org\/10.1016\/j.clineuro.2011.10.047.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"3351_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1001\/jamaneurol.2014.1817","volume":"72","author":"R Fleischmann","year":"2015","unstructured":"Fleischmann R, Pr\u00fcss H, Rosche B, Bahnemann M, Gelderblom H, Deuschle K, et al. Severe cognitive impairment associated with intrathecal antibodies to the NR1 subunit of the N-methyl-D-aspartate receptor in a patient with multiple sclerosis. JAMA Neurol. 2015;72(1):96\u20139. https:\/\/doi.org\/10.1001\/jamaneurol.2014.1817.","journal-title":"JAMA Neurol"},{"issue":"5","key":"3351_CR14","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1212\/NXI.0000000000000141","volume":"2","author":"M Ramberger","year":"2015","unstructured":"Ramberger M, Bsteh G, Schanda K, H\u00f6ftberger R, Rost\u00e1sy K, Baumann M, et al. NMDA receptor antibodies: a rare association in inflammatory diseases. Neurol Neuroimmunol Neuroinflamm. 2015;2(5):e141. https:\/\/doi.org\/10.1212\/NXI.0000000000000141.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"12","key":"3351_CR15","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7(12):1091\u20138. https:\/\/doi.org\/10.1016\/S1474-4422(08)70224-2.","journal-title":"Lancet Neurol"},{"key":"3351_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1212\/WNL.0000000000010310","volume":"95","author":"Maniscalco","year":"2020","unstructured":"Maniscalco, et al. GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis. Neurology. 2020;95:399\u2013401.","journal-title":"Neurology"},{"issue":"5","key":"3351_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/acps.12941","volume":"138","author":"N Warren","year":"2018","unstructured":"Warren N, Siskind D, O'Gorman C. Refining the psychiatric syndrome of anti-N-methyl-D-aspartate receptor encephalitis. Acta Psychiatr Scand. 2018;138(5):401\u20138. https:\/\/doi.org\/10.1111\/acps.12941.","journal-title":"Acta Psychiatr Scand"},{"key":"3351_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fpsyt.2017.00013","volume":"8","author":"Al-Diwani","year":"2017","unstructured":"Al-Diwani, et al. Synaptic and Neuronal Autoantibody-associated Psychiatric Syndromes: Controversies and Hypotheses. Front Psychiatry. 2017;8:13.","journal-title":"Front Psychiatry"},{"issue":"20","key":"3351_CR19","doi-asserted-by":"publisher","first-page":"e1867","DOI":"10.1212\/WNL.0000000000008479","volume":"93","author":"S Mariotto","year":"2019","unstructured":"Mariotto S, Gajofatto A, Batzu L, Delogu R, Sechi G, Leoni S, et al. Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases. Neurology. 2019;93(20):e1867\u201372. https:\/\/doi.org\/10.1212\/WNL.0000000000008479.","journal-title":"Neurology."},{"issue":"17","key":"3351_CR20","doi-asserted-by":"publisher","first-page":"e1866","DOI":"10.1212\/WNL.0000000000009320","volume":"94","author":"HW Kim","year":"2020","unstructured":"Kim HW, Lamb C, Jamali S, Lopez Chiriboga AS. Mystery case: anti-NMDAR encephalitis with overlapping demyelinating syndrome. Neurology. 2020;94(17):e1866\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000009320.","journal-title":"Neurology."}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03351-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-021-03351-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03351-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T03:13:10Z","timestamp":1626059590000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-021-03351-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3351"],"URL":"https:\/\/doi.org\/10.1186\/s12888-021-03351-7","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,12]]},"assertion":[{"value":"25 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Yes. Subject provided written consent for case publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"347"}}